NCT00161902View on ClinicalTrials.gov

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2001

Study Completion Date

March 31, 2003

Conditions
Hip Replacement Surgery
Interventions
DRUG

Fibrin Sealant Vapor-Heated Solvent/Detergent-treated

Trial Locations (7)

1090

Allgemeines Krankenhaus der Stadt Wien, University Clinic for Orthopedics, Vienna

1220

Donauspital im SMZ Ost, Department of Orthopedic Surgery, Vienna

3078

St. Clara Ziekenhuis, Orthopedic Surgery, Rotterdam

3500

A. ö. Krankenhaus Krems, Abteilung f. Orthopädie, Krems

5664

St. Anna Ziekenhuis, Orthopedic Surgery, Geldrop

6229

Academisch Ziekenhuis Maastricht, Orthopedic Surgery, Maastricht

86156

Klinik für Unfall- u. Wiederherstellungschirurgie des Zentralklinikums Augsburg, Augsburg

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT00161902 - Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement | Biotech Hunter | Biotech Hunter